Comparison of two doses of recombinant VIIA (rFVIIA) for producing hemostasis during and after surgery in patients with hemophilia A or B and inhibitors and patients with acquired inhibitors.

被引：0
|
作者：
Cooper, HA
Gilchrist, GS
Hoots, WK
Shapiro, A
机构：
[1] UNC HOSP,CHAPEL HILL,NC
[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[3] INDIANA UNIV,INDIANAPOLIS,IN 46204
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2665 / 2665
页数：1
相关论文
共 50 条
  • [1] Comparison of two doses of recombinant factor VIIa (rFVIIa) for producing hemostasis during and after surgery in patients (PTS) with hemophilia A or B and inhibitors and PTS with acquired inhibitors
    Cooper, HA
    Hoots, WK
    Shapiro, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : SC680 - SC680
  • [2] Home treatment with recombinant factor VIIa (rFVIIa) in hemophilia A or B patients with inhibitors
    Laurian, Y
    Goudemand, J
    Négrier, C
    Vicariot, M
    Marqués-Verdier, A
    Fonlupt, J
    Gaillard, S
    Fressinaud, E
    Dirat, G
    Sultan, Y
    Faradji, A
    Clayessens, S
    Guérois, C
    Peynet, J
    Bertrand, MA
    Digy, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 15 - 15
  • [3] Continous infusion of recombinant VIIa in hemophilia patients with inhibitors.
    Mauser-Bunschoten, EP
    de Goede-Bolder, A
    Wielenga, J
    Levi, M
    Peerlinck, K
    BLOOD, 1998, 92 (10) : 553A - 553A
  • [4] Combination therapy with activated prothrombin complex concentrate (APCC) and recombinant factor VIIa (rFVIIa) in patients with severe hemophilia and inhibitors.
    Schneiderman, J
    Nugent, DJ
    Young, G
    BLOOD, 2002, 100 (11) : 696A - 696A
  • [5] A single mega dose of rFVIIa for treatment of hemophilia patients with inhibitors.
    Kenet, G
    Lubetsky, A
    Luboshitz, J
    Varon, D
    Martinowitz, U
    BLOOD, 2000, 96 (11) : 267A - 267A
  • [6] Use of recombinant factor VIIa (rFVIIa) for surgical hemostasis in congenital hemophilia with inhibitors (CHwI) patients: a Hemophilia and Thrombosis Research Society (HTRS) registry analysis
    Neufeld, E. J.
    Saxena, K.
    Cooper, D. L.
    HAEMOPHILIA, 2011, 17 (03) : 567 - 567
  • [7] Pharmacokinetics of Multiple Doses of rFVIIa in Patients with Hemophilia With and Without Inhibitors
    Stenmo, Camilla
    Fernandez-Bello, Ihosvany
    Ezban, Mirella
    Butta, Nora V.
    Jimenez-Yuste, Victor
    BLOOD, 2014, 124 (21)
  • [8] Successful recombinant factor VIIa (rFVIIa) therapy in two children with hemophilia A and high-responding inhibitors undergoing surgery
    Irsfeld, H
    Mauz-Körholz, C
    Göbel, U
    THROMBOSIS AND HAEMOSTASIS, 1999, : 125 - 125
  • [9] The Mayo Clinic surgical experience, with recombinant factor VIIa (rFVIIa) in patients with congenital hemophilia A (HA) and B (HB) and high titer inhibitors
    Gastineau, DA
    Pruthi, RK
    Moir, CR
    Bolander, ME
    Shaughnessy, WJ
    Farnell, MB
    Koenig, BK
    Gilchrist, GS
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS207 - PS207
  • [10] Randomized, prospective clinical trial of rFVIIa for secondary prophylaxis in hemophilia patients with inhibitors.
    Konkle, Barbara A.
    Ebbesen, Liselotte S.
    Friedrich, Ute
    Bianco, Raul P.
    Lissitchkov, Toshko
    Rusen, Luminita
    Serban, Margit A.
    BLOOD, 2006, 108 (11) : 230A - 230A
12345